Illumina (NASDAQ: ILMN) has developed a targeted set of instruments and chips for organizations conducting larger-scale research in genotyping and gene expression profiling. NASDAQ in Times Square, New York City. ... Genotyping refers to the process of determining the genotype of an individual with a biological assay. ...
Affymetrix has brought a patent suit against Illumina which is scheduled for March 5, 2007. Affymetrix Logo Affymetrix NASDAQ: AFFX was founded by Stephen P.A. Fodor, Ph. ...
Illumina announced the acquisition of Solexa on November 13, 2006. The deal was completed on January 26, 2007. Solexa is now a wholly owned subsidiary of Illumina.
Categories: Companies listed on NASDAQ | Technological company stubs
Share your thoughts, questions and commentary here
Want to know more? Search encyclopedia, statistics and forums:
Press Releases |
The Wikipedia article included on this page is licensed under the
Images may be subject to relevant owners' copyright.
All other elements are (c) copyright NationMaster.com 2003-5. All Rights Reserved.
Usage implies agreement with terms, 1022, m